Pelvic recurrence of cervical cancer. Analysis of 49 surgically treated patients.

被引:0
|
作者
Martino, M
Houvenaeghel, G
Hardwigsen, J
Moutardier, V
Resbeut, M
Delpero, JR
机构
来源
ANNALES DE CHIRURGIE | 1997年 / 51卷 / 01期
关键词
recurrent cervical cancer; central relapses; pelvic side-wall relapses; exenteration; intraoperative radiotherapy;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Pelvic recurrence of cervical cancer is a life-threatening event for patients. The main therapeutic challenge is to locally control such relapses. We present our experience of the surgical treatment of pelvic cervical cancer relapses. Patients and methods: From July 1980 to January 1994, 49 patients underwent a surgical procedure for pelvic cervical cancer relapse. Forty four tumor relapses were localized in the pelvis and 5 were associated with distant metastases. Surgery was performed alone in 31 cases and in association with radiotherapy in 18 cases. Median follow-up was 34 months. Results: The treatment was curative in 49% of cases. There was a significant correlation between the initial stage, the site of tumor relapse and surgical curability. Overall actuarial survival was 44% and 24% at 2 and 5 years, respectively. In the curative treatment group, actuarial survival was 71% and 47% at 2 and 5 years, respectively. There was a major surgical complication in 14 cases: 11 reoperations were performed. Thirteen patients are alive of whom 12 with no evidence of disease (median follow-up : 36 months). A local control was achieved in 53% of cases. Age and site of relapse significantly influenced survival. Conclusions: The results of this study are comparable with other surgical series despite our less favorable patient selection. For patients experiencing pelvic side-wall infiltration, surgical treatment is a worthwhile palliation in selected cases because it is often the only available therapeutic option.
引用
收藏
页码:36 / 45
页数:10
相关论文
共 50 条
  • [31] Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
    Margonis, Georgios Antonios
    Buettner, Stefan
    Andreatos, Nikolaos
    Kim, Yuhree
    Wagner, Doris
    Sasaki, Kazunari
    Beer, Andrea
    Schwarz, Christoph
    Loes, Inger Marie
    Smolle, Maria
    Kamphues, Carsten
    He, Jin
    Pawlik, Timothy M.
    Kaczirek, Klaus
    Poultsides, George
    Lonning, Per Eystein
    Cameron, John L.
    Burkhart, Richard A.
    Gerger, Armin
    Aucejo, Federico N.
    Kreis, Martin E.
    Wolfgang, Christopher L.
    Weiss, Matthew J.
    JAMA SURGERY, 2018, 153 (07)
  • [32] Review of pelvic exenteration in cervical cancer. A description of our casuistics
    Garrido Sanchez, M. C.
    Tello Jimenez, E.
    Liberal Vinagre, M. L.
    Mueller Bravo, A.
    Mestanza Garrido, J. A.
    CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2014, 41 (03): : 122 - 128
  • [33] URINARY POLYAMINES IN PATIENTS WITH ADVANCED CERVICAL-CANCER OR PELVIC CANCER RECURRENCE DURING AND AFTER RADIOTHERAPY
    BECCIOLINI, A
    PORCIANI, S
    LANINI, A
    SANTONI, R
    CIONINI, L
    ACTA ONCOLOGICA, 1992, 31 (03) : 327 - 331
  • [34] Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Lindemann, Kristina
    Smogeli, Elisabeth
    Smastuen, Milada Cvancarova
    Bruheim, Kjersti
    Trovik, Jone
    Nordberg, Terje
    Kristensen, Gunnar B.
    Werner, Henrica M. J.
    Nakken, Esten
    CANCERS, 2021, 13 (06) : 1 - 11
  • [35] SALVAGE TREATMENT OF CENTRAL PELVIC RECURRENCE FOR UTERINE CERVICAL CANCER
    Hathout, L.
    Despres, P.
    Nguyen, T. V.
    Provencher, D.
    Drouin, P.
    Gauthier, P.
    Jolicoeur, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S52 - S52
  • [36] SALVAGE TREATMENT OF CENTRAL PELVIC RECURRENCE OF UTERINE CERVICAL CANCER
    Hathout, L.
    Despres, P.
    Nguyen, T. V.
    Provencher, D.
    Drouin, P.
    Gauthier, P.
    Jolicoeur, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S306 - S306
  • [37] Patterns of recurrence after pelvic exenteration for cervical and vaginal cancer
    Baiocchi, G.
    Faloppa, C.
    Oliveira, R. A. R.
    Kumagai, L. Y.
    Mantoan, H.
    Badiglian-Filho, L.
    Costa, A. A. B. A.
    Guimaraes, G. C.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 196 - 197
  • [38] Adjuvant CMF in node positive breast cancer.: Analysis of 173 patients.
    Valentí, V
    Borràs, JL
    Lainez, N
    Rubió, J
    Creus, J
    Anglada, L
    Villar, JL
    Pelegrí, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S58 - S58
  • [39] Single nucleotide polymorphisms analysis of BRAC and ERCC1 as predictor of recurrence after chemoradiation for cervical cancer patients.
    Roberto Feliz, Luis
    Pereira, Veronica
    Monzo, Mariano
    Munoz, Carmen
    Fuste, Pere
    Gascon, Pedro
    Torrents, A.
    Vidal Boixader, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] ANALYSIS OF PATTERNS OF RECURRENCE ON HISTOLOGICAL SUBTYPES OF CERVICAL CANCER TREATED WITH RADICAL HYSTERECTOMY
    Jeong, E. J.
    Jeong, D. H.
    Byun, J. M.
    Kim, D. H.
    Choi, B. H.
    Kim, M. J.
    Eum, H. M.
    Kim, Y. N.
    Lee, K. B.
    Sung, M. S.
    Kim, K. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 743 - 743